Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility 
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO 
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment 
Iran War Drives Asia's Plastic Crisis — and a Green Packaging Boom 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia 
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
IRVINE, Calif., April 04, 2016 -- Sabra Health Care REIT, Inc. (NASDAQ:SBRA) (NASDAQ:SBRAP) announced today that it has closed on the previously-announced sale of its investments in the Forest Park Medical Center – Frisco hospital. The Company expects to use the proceeds from the sale and repayment of its debtor-in-possession loan investment to repay borrowings under the Company’s revolving credit facility.
ABOUT SABRA
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) (NASDAQ:SBRAP), a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. Sabra leases properties to tenants and operators throughout the United States and Canada.
The Sabra Health Care REIT, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=8563
Contact: Investor & Media Inquiries: (949) 679-0410
